Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. (Q53265340)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 October 2010

Language	Label	Description	Also known as
English	Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.	scientific article published on 19 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Parkinson's disease

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christine Brefel-Courbon

10

object named as

Christine Brefel-Courbon

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

Fabienne Ory-Magne

3

object named as

Fabienne Ory-Magne

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

9

object named as

Pierre Payoux

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

author name string

Estelle Dellapina

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Angélique Gerdelat-Mas

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Laure Pourcel

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Monique Galitzky

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Fabienne Calvas

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Marion Simonetta-Moreau

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Claire Thalamas

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

language of work or name

0 references

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

26

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

153-157

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Pain in Parkinson's disease: Prevalence and characteristics

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Noradrenergic pain modulation

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Method for quantitative estimation of thermal thresholds in patients

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

A quantitative somatosensory testing of pain threshold in individuals with mental retardation.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Biochemical aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Stages in the development of Parkinson's disease-related pathology

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23406

21 January 2018

Identifiers

10.1002/MDS.23406

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20960436

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53265340&oldid=2015672621"